ATE310509T1 - Methode zur behandlung eines analgesiebedürftigen patienten - Google Patents

Methode zur behandlung eines analgesiebedürftigen patienten

Info

Publication number
ATE310509T1
ATE310509T1 AT03708305T AT03708305T ATE310509T1 AT E310509 T1 ATE310509 T1 AT E310509T1 AT 03708305 T AT03708305 T AT 03708305T AT 03708305 T AT03708305 T AT 03708305T AT E310509 T1 ATE310509 T1 AT E310509T1
Authority
AT
Austria
Prior art keywords
analgesia
patient
treating
need
devazepide
Prior art date
Application number
AT03708305T
Other languages
English (en)
Inventor
Karen Jackson
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Application granted granted Critical
Publication of ATE310509T1 publication Critical patent/ATE310509T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Laser Surgery Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Radiation-Therapy Devices (AREA)
  • Confectionery (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03708305T 2002-01-22 2003-01-22 Methode zur behandlung eines analgesiebedürftigen patienten ATE310509T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201367.0A GB0201367D0 (en) 2002-01-22 2002-01-22 Composition
PCT/GB2003/000221 WO2003061632A1 (en) 2002-01-22 2003-01-22 Method of treatment of a patient requiring analgesia

Publications (1)

Publication Number Publication Date
ATE310509T1 true ATE310509T1 (de) 2005-12-15

Family

ID=9929492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708305T ATE310509T1 (de) 2002-01-22 2003-01-22 Methode zur behandlung eines analgesiebedürftigen patienten

Country Status (13)

Country Link
EP (1) EP1467718B1 (de)
JP (1) JP2005521655A (de)
AT (1) ATE310509T1 (de)
BR (1) BR0307022A (de)
CA (1) CA2473884A1 (de)
DE (1) DE60302431T2 (de)
ES (1) ES2253662T3 (de)
GB (1) GB0201367D0 (de)
IL (1) IL162768A0 (de)
MX (1) MXPA04007030A (de)
NO (1) NO20042758L (de)
PL (1) PL371523A1 (de)
WO (1) WO2003061632A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213198D0 (en) * 2002-06-10 2002-07-17 Ml Lab Plc Method of treatment
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
CA2622592A1 (en) 2005-09-19 2007-03-29 Arrow Therapeutics Limited Benzodiazepine derivatives for treating hepatitis c infection
EP2089010A1 (de) * 2006-10-24 2009-08-19 The John Hopkins University Minitabletten mit schneller freisetzung zur analgesie in labortieren
JP2010539184A (ja) * 2007-09-12 2010-12-16 エラン・ファルマ・インターナショナル・リミテッド 投薬レジメン
US9168251B2 (en) * 2010-09-03 2015-10-27 Zoetis Belgium S.A High dose buprenorphine compositions and use as analgesic
US20120171277A1 (en) * 2011-01-03 2012-07-05 Royds Robert B Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
CN121265577A (zh) 2020-05-18 2026-01-06 奥瑞克索股份公司 用于药物递送的药物组合物
TW202333658A (zh) 2021-11-25 2023-09-01 瑞典商奥瑞克索股份公司 包含腎上腺素之新穎醫藥組合物
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564039A (en) * 1976-12-09 1980-04-02 Berger F Analgesic compositions comprising dextropropoxyphene and benzodiazepines
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
CA2473884A1 (en) 2003-07-31
DE60302431T2 (de) 2006-07-27
NO20042758L (no) 2004-09-22
IL162768A0 (en) 2005-11-20
MXPA04007030A (es) 2004-10-11
WO2003061632A1 (en) 2003-07-31
EP1467718B1 (de) 2005-11-23
ES2253662T3 (es) 2006-06-01
DE60302431D1 (de) 2005-12-29
GB0201367D0 (en) 2002-03-13
JP2005521655A (ja) 2005-07-21
PL371523A1 (en) 2005-06-27
EP1467718A1 (de) 2004-10-20
BR0307022A (pt) 2004-11-03

Similar Documents

Publication Publication Date Title
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
DE60302431D1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
WO2004056305A3 (en) Administration of capsaicinoids
ATE394097T1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
IS2630B (is) Meðferð á fráhvarfseinkennum
TW200420290A (en) Methods for the treatment, prevention and management of macular degeneration
JO3446B1 (ar) طريقة لمعالجة الأرق الأولي
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
SE9902597D0 (sv) New use
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
UA81689C2 (ru) Способ предоперационного лечения послеоперационной боли бупренорфином
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
DE60020550D1 (de) Methode und mittel zur behandlung eines post-poliosyndroms
IL164092A0 (en) The use of devazepide as analgesic agent
WO2003072737A3 (en) Biological inhibitions induced by contact inhibitory factor
DK1351676T3 (da) Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer

Legal Events

Date Code Title Description
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee